neuroClues

neuroClues

Private
Louvain-la-NeuveHealthcare & Life Scienceshttps://neuroclues.com/

Last Round

Series A

Apr 7, 2026

Total Funding Raised

$25.15M

Company Overview

neuroClues is a medtech company that provides an AI-driven eye-tracking device for clinicians to aid in the early diagnosis of neurological disorders such as Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

eye-tracking deviceAI medical deviceneurological diagnosisneurotechdigital biomarkersearly diagnosisParkinson's diagnosisAlzheimer's diagnosisnon-invasive diagnosticsclinical decision supportcomputer visioneye movement analysismedical device softwareCE marked deviceFDA clearancemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

neuroClues Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

neuroClues Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 7, 2026
Series AApr 30, 2024
GrantDec 19, 2022
SeedNov 8, 2021

Key People

Founding team and executive leadership

Pierre Daye

CTO, Founder

Founding Team

Antoine Pouppez

Co-Founder CEO

Founding Team

neuroClues Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    $12M round closed.

neuroClues Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

neuroClues Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about neuroClues's valuation, stock price, and market status.

Firmographic Details

HeadquartersLouvain-la-Neuve
Employee Range29
Year Founded2020
Last FundingApr 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.